ReviewTherapeutic advances in hematology2017

Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.

Ahmet Emre Eskazan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.